Sutro Biopharma Stock Forward View - Daily Balance Of Power
| STRO Stock | USD 15.64 1.66 11.87% |
Sutro Stock outlook is based on your current time horizon.
As of today the rsi of Sutro Biopharma's share price is below 20 . This usually implies that the stock is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards. Momentum 0
Sell Peaked
Oversold | Overbought |
Using Sutro Biopharma hype-based prediction, you can estimate the value of Sutro Biopharma from the perspective of Sutro Biopharma response to recently generated media hype and the effects of current headlines on its competitors.
Sutro Biopharma after-hype prediction price | USD 14.72 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Sutro Biopharma to cross-verify your projections. Sutro Biopharma Additional Predictive Modules
Most predictive techniques to examine Sutro price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Sutro using various technical indicators. When you analyze Sutro charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Previous Daily Balance Of Power | Daily Balance Of Power | Trend |
| (0.81) | 0.5929 |
| Check Sutro Biopharma Volatility | Backtest Sutro Biopharma | Information Ratio |
Sutro Biopharma Trading Date Momentum
| On February 10 2026 Sutro Biopharma was traded for 15.64 at the closing time. The top price for the day was 17.80 and the lowest listed price was 15.00 . The trading volume for the day was 559.3 K. The trading history from February 10, 2026 did not result in any price rise and fall. The trading price change against the current closing price is 8.76% . |
Balance of Power indicator was created by Igor Livshin to predict asset short term price movements or warning signals. If Balance of Power indicator is trended towards the high of its range it will signify that the bulls are in control. On the other hand when the BOP indicator is moving towards the lows of its range it signifies that the bears are in control. If the indicator move from a high positive range to a lower positive range it signifies that the buying pressure is decreasing. Conversely, if the indicator move from a low negative range to a higher negative range it signifies that the selling pressure is decreasing.
| Compare Sutro Biopharma to competition |
Other Forecasting Options for Sutro Biopharma
For every potential investor in Sutro, whether a beginner or expert, Sutro Biopharma's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Sutro Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Sutro. Basic forecasting techniques help filter out the noise by identifying Sutro Biopharma's price trends.Sutro Biopharma Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Sutro Biopharma stock to make a market-neutral strategy. Peer analysis of Sutro Biopharma could also be used in its relative valuation, which is a method of valuing Sutro Biopharma by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Sutro Biopharma Market Strength Events
Market strength indicators help investors to evaluate how Sutro Biopharma stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Sutro Biopharma shares will generate the highest return on investment. By undertsting and applying Sutro Biopharma stock market strength indicators, traders can identify Sutro Biopharma entry and exit signals to maximize returns.
| Accumulation Distribution | 87978.67 | |||
| Daily Balance Of Power | 0.5929 | |||
| Rate Of Daily Change | 1.12 | |||
| Day Median Price | 16.4 | |||
| Day Typical Price | 16.15 | |||
| Price Action Indicator | 0.07 | |||
| Period Momentum Indicator | 1.66 |
Sutro Biopharma Risk Indicators
The analysis of Sutro Biopharma's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Sutro Biopharma's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting sutro stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 5.08 | |||
| Semi Deviation | 4.9 | |||
| Standard Deviation | 6.56 | |||
| Variance | 43.0 | |||
| Downside Variance | 35.22 | |||
| Semi Variance | 24.06 | |||
| Expected Short fall | (5.70) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Sutro Biopharma
The number of cover stories for Sutro Biopharma depends on current market conditions and Sutro Biopharma's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Sutro Biopharma is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Sutro Biopharma's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Sutro Biopharma Short Properties
Sutro Biopharma's future price predictability will typically decrease when Sutro Biopharma's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Sutro Biopharma often depends not only on the future outlook of the potential Sutro Biopharma's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Sutro Biopharma's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 7.7 M | |
| Cash And Short Term Investments | 316.9 M |
Check out Historical Fundamental Analysis of Sutro Biopharma to cross-verify your projections. To learn how to invest in Sutro Stock, please use our How to Invest in Sutro Biopharma guide.You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Will Biotechnology sector continue expanding? Could Sutro diversify its offerings? Factors like these will boost the valuation of Sutro Biopharma. If investors know Sutro will grow in the future, the company's valuation will be higher. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Sutro Biopharma data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Understanding Sutro Biopharma requires distinguishing between market price and book value, where the latter reflects Sutro's accounting equity. The concept of intrinsic value - what Sutro Biopharma's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push Sutro Biopharma's price substantially above or below its fundamental value.
Please note, there is a significant difference between Sutro Biopharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Sutro Biopharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. In contrast, Sutro Biopharma's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.